TABLE 1.
HAP form | Treatment time (h) | Effectb of HAP form at a dose of:
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
4 μg | 2 μg | 1 μg | 500 ng | 250 ng | 125 ng | 62.5 ng | 31.25 ng | 15.6 ng | ||
45 kDaa | 24 | CR | CR | CR | CR | |||||
48 | CR | CR | CR | CR | CD | |||||
72 | CR | CR | CR | CR | CR | CD | CD | |||
90 | CR | CR | CR | CR | CR | CR | CR | CD | ||
35 kDa | 24 | CR | CR | CR | CR | CR | ||||
48 | CR | CR | CR | CR | CR | CR | CR | CR | CR |
After dialysis in EDTA-free buffer.
CR, cell rounding; CD, cell distension.